Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial

BACKGROUND: Paediatric dolutegravir doses approved by stringent regulatory authorities (SRAs) for children weighing 20 kg to less than 40 kg until recently required 25 mg and 10 mg film-coated tablets. These tablets are not readily available in low-resource settings where the burden of HIV is highes...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Lancet HIV
Main Authors: Bollen, Pauline D J, Moore, Cecilia L, Mujuru, Hilda A, Makumbi, Shafic, Kekitiinwa, Adeodata R, Kaudha, Elisabeth, Parker, Anna, Musoro, Godfrey, Nanduudu, Annet, Lugemwa, Abbas, Amuge, Pauline, Hakim, James G, Rojo, Pablo, Giaquinto, Carlo, Colbers, Angela, Gibb, Diana M, Ford, Deborah, Turkova, Anna, Burger, David M
Format: Artigo
Jezik:Inglês
Izdano: Elsevier B.V 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7445428/
https://ncbi.nlm.nih.gov/pubmed/32763217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3018(20)30189-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki